• APHL Responds to the Zika Virus

    APHL Responds to the Zika Virus

    Status updates on Zika diagnostics, guidance, training and response activities. More.
Our Work

Through its scientific programs, APHL advances public health testing and surveillance systems in the US and globally.


Featured Resources

Tools to achieve your food safety goals.

 

 

Food Safetyhttp://redesign.dev.aphl.org/programs/Lists/Highlighted Content/DispForm.aspx?ID=1Food Safety<img alt="" src="/PublishingImages/FS_DeptSubpage.png" style="BORDER:0px solid;" />http://redesign/programs/food_safety/Pages/APHL-Food-Safety.aspx, http://redesign.dev.aphl.org/programs/food_safety/Pages/APHL-Food-Safety.aspx
Informaticshttp://redesign.dev.aphl.org/programs/Lists/Highlighted Content/DispForm.aspx?ID=2Informatics<img alt="" src="/PublishingImages/About%20APHL%203.gif" style="BORDER:0px solid;" />http://redesign/programs/informatics/Pages/Technical-Assistance-for-Data-Exchange.aspx, http://redesign.dev.aphl.org/programs/informatics/Pages/Technical-Assistance-for-Data-Exchange.aspx
Global Healthhttp://redesign.dev.aphl.org/programs/Lists/Highlighted Content/DispForm.aspx?ID=3Global Health<img alt="" src="/PublishingImages/GH-labdepartment.jpg" style="BORDER:0px solid;" />http://redesign/programs/global_health/Pages/default.aspx, http://redesign.dev.aphl.org/programs/global_health/Pages/default.aspx

 

 

2015 All-Hazards Survey Reporthttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/PHPR-2015-All-Hazards-52016-digital.pdf2015 All-Hazards Survey ReportEach year, APHL surveys PHLs to assess their readiness to respond to threats and identify challenges that affect rapid response. This year's survey covers the 12-month period from 7/1/14 - 6/30/15, representing FY14 CDC PHEP Cooperative Agreement, BP 3.
Guidance for State Medical Cannabis Testinghttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/EH-Guide-State-Med-Cannabis-052016.pdfGuidance for State Medical Cannabis Testing
MTBC Drug Susceptibility Testing: EMBhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-MTBC_DrugSusceptibility_0216.pdfMTBC Drug Susceptibility Testing: EMBA discussion of issues surrounding the use of the anti-tuberculosis drug Ethambutol, or EMB, including recommended dose, EMB drug susceptibility testing and test methods, and reproducibility of susceptibility testing for EMB.
MTBC Drug Susceptibility Testing: PZAhttp://redesign.dev.aphl.org/aboutAPHL/publications/Documents/ID-PZA_WhitePaper_0216.pdfMTBC Drug Susceptibility Testing: PZAA discussion about the use of Pyrazinimide, or PZA, as first-line therapy for treatment of Mycobacterium tuberculosis complex, including mechanism of action, reproducibility of susceptibility testing, and impact on clinical outcomes.